Vnitr Lek 2008, 54(2):133-134

Invazivní aspergilóza: je čas na optimizmus? - editorial

E. Faber
Hemato-onkologická klinika Lékařské fakulty UP a FN Olomouc, přednosta prof. MUDr. Karel Indrák, DrSc.

Received: December 5, 2007; Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Faber E. Invazivní aspergilóza: je čas na optimizmus? - editorial. Vnitr Lek. 2008;54(2):133-134.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Patterson TF. Advances and challenges in managemet of invasive mycoses. Lancet 2005; 366: 1013-1025. Go to original source... Go to PubMed...
    2. Chamilos G, Luna M, Lewis RE et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91: 986-989. Go to PubMed...
    3. Haber J. Mezinárodní konsensus k definici invazivních mykotických infekcí u nemocných s maligním onemocněním a po transplantaci hemopoetických buněk. Transfuz Hemat dnes 2002; 2: 72-76.
    4. Maertens J, Theunissen K, Verhoef G et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41: 1242-1250. Go to original source... Go to PubMed...
    5. Greene RE, Schlamm HT, Oestmann JW et al. Imaging findings in acute invasive pulmonary aspergilosis: Clinical significance of the halo sign. Clin Infect Dis 2007; 44: 373-379. Go to original source... Go to PubMed...
    6. Aquino VR, Goldani LZ, Pasqualotto AC. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia 2007; 163: 191-202. Go to original source... Go to PubMed...
    7. Ráčil Z, Mayer J, Kocmanová I. et al. Invazivní aspergilové infekce u hematoonkologických nemocných: význam jednotlivých diagnostických metod, léčebných postupů a nástin finanční náročnosti léčby. Vnitř Lék 2008; 54: 157-168. Go to PubMed...
    8. Singh N, Limaye AP, Forrest G et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 2006; 81: 320-326. Go to original source... Go to PubMed...
    9. Mayer J, Skřičková, Vorlíček J et al. Použití bronchopulmonální laváže v diagnostice plicních komplikací imunokompromitovaných pacientů. Vnitř Lék 1994; 40: 179-183. Go to PubMed...
    10. Mayer J, Skřičková, Vorlíček J et al. Plicní infekce způsobené Pneumocystis carinii u nemocných s maligním onemocněním krvetvorby. Vnitř Lék 1994; 40: 591-594. Go to PubMed...
    11. Ráčil Z, Kocmanová I, Wagnerová B et al. Časná diagnostiky invazivních u hematologických pacientů sérologickými metodami. Vnitř Lék 2007; 53: 990-999. Go to PubMed...
    12. Bartáková H, Cetkovský, Drgoňa Ľ et al. Invazivní aspergilóza: současné možnosti diagnostiky. Vnitř Lék 2007; 53(Suppl): S1-S34.
    13. Racil Z, Kocmanova I, Lengerova M et al. Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum. J Clin Microbiol 2007; 45: 3141-3142. Go to original source... Go to PubMed...
    14. Haber J, Čermák J, Indrák K et al. Stanovisko odborných společností k indikaci a použití antimykotik se systémovým účinkem. Klin Onkol 2003; 16: 234-238.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.